Alan Fournier, Pennant Capital Boost Stake in BioScrip

Alan Fournier‘s hedge fund, Pennant Capital Management, reported in a new filing boosting its exposure at BioScrip Inc (NASDAQ:BIOS) to some 5.74 million shares, from 1.64 million disclosed in its latest 13F. The stake is passive by nature and amasses 8.44% of BioScrip’s common stock.


Disclosure: none

Recommended Reading:

Ariel Investments Reports More Moves Into Dover Motorsports, Edgewater Technology & Others

Cannell Discloses Holding 5.54M Shares of ValueVision

John Rogers, Ariel Also Disclose a 10.9% Stake in Cumberland Pharmaceuticals